Granted Patent
B2
US 12,344,865 · App. 17/776,900 · Granted Jul 1, 2025
Biocatalysts and methods for hydroxylation of chemical compounds
Inventors:
Jonathan Vroom (South San Francisco, CA); Alberto Ortega Guerra (Menlo Park, CA); Jack Liang (South San Francisco, CA); Gregory A. Cope (Menlo Park, CA); Nikki Dellas (San Carlos, CA); Christopher Keltie Prier (Rahway, NJ)
Assignee:
Codexis, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention provides engineered proline hydroxylase polypeptides for the production of hydroxylated compounds, polynucleotides encoding the engineered proline hydroxylases, host cells capable of expressing the engineered proline hydroxylases, and methods of using the engineered proline hydroxylases to prepare compounds useful in the production of active pharmaceutical agents.
Claims (7)
1. An engineered polypeptide having proline hydroxylase activity, comprising an amino acid sequence having at least 80% sequence identity to the amino acid sequence of SEQ ID NO: 4, and further comprising one or more amino acid substitutions as compared to SEQ ID NO: 4 at positions selected from the group consisting of: 194, 123, 21, 28, 58/247, 65, 80, 85, 95, 98, 117, 120, 159, 185, 199, 200, 233, 237, 243, 250, 268, 281, 282, 287, 289, 307, 324, 326, 327, 330, 338, 343, 346, and 348.
2. The engineered polypeptide of claim 1 , comprising an amino acid sequence having at least 80% sequence identity to the amino acid sequence of SEQ ID NO: 4, and further comprising a combination of amino acid substitutions as compared to SEQ ID NO: 4 at positions selected from the group consisting of: 48/66/189, 48/66, and 66/82/85/135/189/267.
3. The engineered polypeptide of claim 2 , comprising an amino acid sequence having at least 85% sequence identity to the amino acid sequence of SEQ ID NO: 4, and further comprising one or more amino acid substitutions as compared to SEQ ID NO: 4 at positions selected from the group consisting of: 21, 29, 44, 76, 85, 117, 120, 123, 129, 135, 139, 147, 162, 175, 179, 189, 195, 199, 208, 219, 228, 233, 236, 237, 243, 262, 277, 278, 281, 282, 289, 296, 307, 324, 326, 330, 335, 343, 345, and 347.
4. The engineered polypeptide of claim 1 , wherein said polypeptide has at least 80% sequence identity to at least one amino acid sequence selected from the group consisting of SEQ ID NOs: 6, 8, 116, 118, 120, 156, 158, 160, 162, 164, 166, 168, 170, 172,174, 176, 178, 180, 182, 184, 186, 188, 190, 192, 194, 196, 198, 200, 202, 204, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 226, 228, 230, 232, 234, 236, 238, 240, 242, 244, 246, 248, 250, 252, 254, 256, 258, 260, 262, 264, 266, 268, 270, 272, 274, 276, 278, 280, 282, 284, 286, 288, 290, 292, 294, 296, 298, 300, 302, 304, 306, 308, 310, 312, 314, 316, 318, 320, 322, 324, 326, 328, 330, 332, 334, 336, 338, 340, 342, 344, 346, 348, 350, 352, 354, 356, 358, 360, 362, 364, 366, 368, 370, 372, 374, 376, 378, 380, 382, 384, 386, 388, 390, 392, 394, 396, 398, 400, 402, 404, 406, 408, 410, 412, 414, 416, 418, 420, 422, 424, 426, 428, 430, 432, 434, 436, 438, 440, 442, 444, 446, 448, 450,452, 454, 456, 458, 460, 462, 464, 466, 468, 470, 472, 474 476, 478, 480, 482, 484, 486, 488, 490, 492, 494, 496, 498, 500, 502, 504, 506 508, 510, 512, 514, 516, 518, 520, 522, 524, 526, 528, 530, 532, 534, 536, 538, 540, 542, 544, 546, 548, 550, 552, 554, 556, 558, 560, 562, 564, 566, 568, 570, 572, 574, 576, 578, 580, 582, 584, 586, 588, 590, 592, 594, 596, 598, 600, 602, 604, 606, 608, 610, 612, 614, 616, 618, 620, 622, 624, 626, 628, 630, 632, 634, 636, 638, 640, 642, 644, 646, 648, 650, 652, 654, 656 and 658.
5. A polynucleotide comprising a nucleotide sequence encoding the engineered polypeptide of claim 1 .
6. A polynucleotide comprising a nucleotide sequence encoding the engineered polypeptide of claim 4 .
7. The engineered polypeptide of claim 1 , comprising an amino acid sequence having at least 87% sequence identity to the amino acid sequence of SEQ ID NO: 4, comprising a substitution as compared to SEQ ID NO: 4 at position 194, and wherein the substitution at position 194 is 194L.
Assignments (2)
SECURITY INTEREST
Recorded Feb 15, 2024
From: CODEXIS, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
Reel/Frame 066600/0650 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Feb 9, 2024
From: VROOM, JONATHAN; ORTEGA, ALBERTO GUERRA; LIANG, JACK; COPE, GREGORY A.; DELLAS, NIKKI; VROOM, JONATHAN; ORTEGA, ALBERTO GUERRA; LIANG, JACK; COPE, GREGORY A.; DELLAS, NIKKI
To: CODEXIS, INC.
Reel/Frame 066432/0234 →
Continuity (2)
Provisional Application
62940647
· Nov 26, 2019
References Cited (233)
US 5364775A
· Katsumata et al.
· 1994
[cited by applicant]
US 5605793A
· Stemmer
· 1997
[cited by applicant]
US 5811238A
· Stemmer et al.
· 1998
[cited by applicant]
US 5830721A
· Stemmer et al.
· 1998
[cited by applicant]
US 5834252A
· Stemmer et al.
· 1998
[cited by applicant]
US 5837458A
· Minshull et al.
· 1998
[cited by applicant]
US 5854040A
· Ozaki et al.
· 1998
[cited by applicant]
US 5928905A
· Stemmer et al.
· 1999
[cited by applicant]
US 5962292A
· Ozaki et al.
· 1999
[cited by applicant]
US 5963254A
· Kim et al.
· 1999
[cited by applicant]
US 6096548A
· Stemmer
· 2000
[cited by applicant]
US 6117679A
· Stemmer
· 2000
[cited by applicant]
US 6132970A
· Stemmer
· 2000
[cited by applicant]
US 6165793A
· Stemmer
· 2000
[cited by applicant]
US 6180406B1
· Stemmer
· 2001
[cited by applicant]
US 6251674B1
· Tobin et al.
· 2001
[cited by applicant]
US 6265201B1
· Wackett et al.
· 2001
[cited by applicant]
US 6277638B1
· Stemmer
· 2001
[cited by applicant]
US 6287861B1
· Stemmer et al.
· 2001
[cited by applicant]
US 6287862B1
· delCardayre et al.
· 2001
[cited by applicant]
US 6291242B1
· Stemmer
· 2001
[cited by applicant]
US 6297053B1
· Stemmer
· 2001
[cited by applicant]
US 6303344B1
· Patten et al.
· 2001
[cited by applicant]
US 6309883B1
· Minshull et al.
· 2001
[cited by applicant]
US 6319713B1
· Patten et al.
· 2001
[cited by applicant]
US 6319714B1
· Crameri et al.
· 2001
[cited by applicant]
US 6323030B1
· Stemmer
· 2001
[cited by applicant]
US 6326204B1
· delCardayre et al.
· 2001
[cited by applicant]
US 6335160B1
· Patten et al.
· 2002
[cited by applicant]
US 6335198B1
· delCardayre et al.
· 2002
[cited by applicant]
US 6337186B1
· Krebber
· 2002
[cited by applicant]
US 6344356B1
· Stemmer
· 2002
[cited by applicant]
US 6352859B1
· delCardayre et al.
· 2002
[cited by applicant]
US 6355484B1
· Patten et al.
· 2002
[cited by applicant]
US 6358740B1
· Patten et al.
· 2002
[cited by applicant]
US 6358742B1
· Stemmer
· 2002
[cited by applicant]
US 6365377B1
· Patten et al.
· 2002
[cited by applicant]
US 6365408B1
· Stemmer
· 2002
[cited by applicant]
US 6368861B1
· Crameri et al.
· 2002
[cited by applicant]
US 6372497B1
· Stemmer
· 2002
[cited by applicant]
US 6376246B1
· Crameri et al.
· 2002
[cited by applicant]
US 6379964B1
· delCardayre et al.
· 2002
[cited by applicant]
US 6387702B1
· Stemmer
· 2002
[cited by applicant]
US 6391552B2
· Stemmer
· 2002
[cited by applicant]
US 6391640B1
· Minshull et al.
· 2002
[cited by applicant]
US 6395547B1
· Stemmer
· 2002
[cited by applicant]
US 6406855B1
· Patten et al.
· 2002
[cited by applicant]
US 6406910B1
· Patten et al.
· 2002
[cited by applicant]
US 6413745B1
· Patten et al.
· 2002
[cited by applicant]
US 6413774B1
· Stemmer
· 2002
[cited by applicant]
US 6420175B1
· Stemmer
· 2002
[cited by applicant]
US 6423542B1
· Crameri et al.
· 2002
[cited by applicant]
US 6426224B1
· Crameri et al.
· 2002
[cited by applicant]
US 6436675B1
· Welch et al.
· 2002
[cited by applicant]
US 6444468B1
· Stemmer et al.
· 2002
[cited by applicant]
US 6455253B1
· Patten et al.
· 2002
[cited by applicant]
US 6479652B1
· Crameri et al.
· 2002
[cited by applicant]
US 6482647B1
· Stemmer
· 2002
[cited by applicant]
US 6483011B1
· Stemmer et al.
· 2002
[cited by applicant]
US 6484105B2
· Zhang
· 2002
[cited by applicant]
US 6489146B2
· Stemmer et al.
· 2002
[cited by applicant]
US 6500617B1
· Stemmer et al.
· 2002
[cited by applicant]
US 6500639B2
· Subramanian
· 2002
[cited by applicant]
US 6506602B1
· Stemmer
· 2003
[cited by applicant]
US 6506603B1
· Stemmer
· 2003
[cited by applicant]
US 6518065B1
· Stemmer
· 2003
[cited by applicant]
US 6519065B1
· Colbourne et al.
· 2003
[cited by applicant]
US 6521453B1
· Crameri et al.
· 2003
[cited by applicant]
US 6528311B1
· delCardayre et al.
· 2003
[cited by applicant]
US 6537746B2
· Arnold et al.
· 2003
[cited by applicant]
US 6573098B1
· Stemmer
· 2003
[cited by applicant]
US 6576467B1
· Stemmer
· 2003
[cited by applicant]
US 6579678B1
· Patten et al.
· 2003
[cited by applicant]
US 6586182B1
· Patten et al.
· 2003
[cited by applicant]
US 6602986B1
· Stemmer et al.
· 2003
[cited by applicant]
US 6605430B1
· Affholter et al.
· 2003
[cited by applicant]
US 6613514B2
· Patten et al.
· 2003
[cited by applicant]
US 6653072B1
· Patten et al.
· 2003
[cited by applicant]
US 6686515B1
· Lassner et al.
· 2004
[cited by applicant]
US 6703240B1
· Stemmer et al.
· 2004
[cited by applicant]
US 6716631B1
· delCardayre et al.
· 2004
[cited by applicant]
US 6825001B2
· Wackett et al.
· 2004
[cited by applicant]
US 6902922B2
· Ness et al.
· 2005
[cited by applicant]
US 6917882B2
· Selifonov et al.
· 2005
[cited by applicant]
US 6946296B2
· Patten et al.
· 2005
[cited by applicant]
US 6961664B2
· Selifonov et al.
· 2005
[cited by applicant]
US 6995017B1
· Stemmer
· 2006
[cited by applicant]
US 7024312B1
· Selifonov et al.
· 2006
[cited by applicant]
US 7058515B1
· Selifonov et al.
· 2006
[cited by applicant]
US 7105297B2
· Minshull et al.
· 2006
[cited by applicant]
US 7148054B2
· delCardayre et al.
· 2006
[cited by applicant]
US 7220566B2
· Ness et al.
· 2007
[cited by applicant]
US 7288375B2
· Stemmer et al.
· 2007
[cited by applicant]
US 7384387B1
· Raillard et al.
· 2008
[cited by applicant]
US 7462469B2
· Raillard et al.
· 2008
[cited by applicant]
US 7421347B2
· Selifonov et al.
· 2008
[cited by applicant]
US 7430477B2
· Selifonov et al.
· 2008
[cited by applicant]
US 7534564B2
· Patten et al.
· 2009
[cited by applicant]
US 7620500B2
· Mundorff et al.
· 2009
[cited by applicant]
US 7620502B2
· Selifonov et al.
· 2009
[cited by applicant]
US 7629170B2
· delCardayre et al.
· 2009
[cited by applicant]
US 7702464B1
· Emig et al.
· 2010
[cited by applicant]
US 7747391B2
· Gustafsson et al.
· 2010
[cited by applicant]
US 7747393B2
· Fox
· 2010
[cited by applicant]
US 7751986B2
· Gustafsson et al.
· 2010
[cited by applicant]
US 7776598B2
· Patten et al.
· 2010
[cited by applicant]
US 7783428B2
· Gustafsson et al.
· 2010
[cited by applicant]
US 7795030B2
· Minshull et al.
· 2010
[cited by applicant]
US 7853410B2
· Selifonov et al.
· 2010
[cited by applicant]
US 7868138B2
· Stemmer et al.
· 2011
[cited by applicant]
US 7873477B1
· Gustafsson et al.
· 2011
[cited by applicant]
US 7873499B2
· Selifonov et al.
· 2011
[cited by applicant]
US 7904249B2
· Selifonov et al.
· 2011
[cited by applicant]
US 7957912B2
· Selifonov et al.
· 2011
[cited by applicant]
US 7981614B2
· Stemmer et al.
· 2011
[cited by applicant]
US 8014961B2
· Bass et al.
· 2011
[cited by applicant]
US 8029988B2
· Crameri et al.
· 2011
[cited by applicant]
US 8048674B2
· Minshull et al.
· 2011
[cited by applicant]
US 8058001B2
· Minshull et al.
· 2011
[cited by applicant]
US 8076138B2
· delCardayre et al.
· 2011
[cited by applicant]
US 8108150B2
· Mundorff et al.
· 2012
[cited by applicant]
US 8170806B2
· Selifonov et al.
· 2012
[cited by applicant]
US 8224580B2
· Mundorff et al.
· 2012
[cited by applicant]
US 8377681B2
· delCardayre et al.
· 2013
[cited by applicant]
US 8383346B2
· Colbeck et al.
· 2013
[cited by applicant]
US 8457903B1
· Emig et al.
· 2013
[cited by applicant]
US 8504498B2
· Fox
· 2013
[cited by applicant]
US 8589085B2
· Selifonov et al.
· 2013
[cited by applicant]
US 8762066B2
· Fox
· 2014
[cited by applicant]
US 8768871B2
· Fox
· 2014
[cited by applicant]
US 8849575B2
· Gustafsson et al.
· 2014
[cited by applicant]
US 9593326B2
· Clark et al.
· 2017
[cited by applicant]
US 20060195947A1
· Davis et al.
· 2006
[cited by applicant]
US 20080220990A1
· Fox
· 2008
[cited by applicant]
US 20090312196A1
· Colbeck et al.
· 2009
[cited by applicant]
US 20110091942A1
· Kino et al.
· 2011
[cited by applicant]
EP 0641862B1
· 2001
[cited by applicant]
EP 2290065B1
· 2014
[cited by applicant]
WO 9522625A1
· 1995
[cited by applicant]
WO 9533836A1
· 1995
[cited by applicant]
WO 9600787A1
· 1996
[cited by applicant]
WO 970078A1
· 1997
[cited by applicant]
WO 9735966A1
· 1997
[cited by applicant]
WO 9827230A1
· 1998
[cited by applicant]
WO 200042651A1
· 2000
[cited by applicant]
WO 200175767A2
· 2001
[cited by applicant]
WO 2009008908A2
· 2009
[cited by applicant]
WO 2009139365A1
· 2009
[cited by applicant]
WO 2009152336A1
· 2009
[cited by applicant]
WO 2010144103A1
· 2010
[cited by applicant]
Kaelin et al. (Annu Rev Biochem, 2005, 74:115) (Year: 2005).
[cited by examiner]
Matsui, M., et al., “Genome Sequence of Fungal Species No. 11243, Which Produces the Antifungal Antibiotic FR901469,” Genome Announcements, 3(2):1-2 [2015].
[cited by applicant]
WO2021108209; Written Opinion of International Searching Authority; Apr. 7, 2021.
[cited by applicant]
Ramaswarmy, S.G., et al., “One-vessel synthesis of 4-hydroxyproline from glyoxal and oxaloacetic acid,” J. Org. Chem., 42(21):3440-3443 [1977].
[cited by applicant]
Remuzon, P., “Trans-4-hydroxy-L-proline, a useful and versatile chiral starting block,” Tetrahedron, 52 (44):13803-13835 [1996].
[cited by applicant]
Romanos, M.A., et al., “Foreign gene expression in yeast: a review,” Yeast 8:423-488 [1992].
[cited by applicant]
Rychlik, W., et al., “Optimization of the annealing temperature for DNA amplification in vitro,” Nucleic Acids Res, 18 (21):6409-6412 (1990).
[cited by applicant]
Shibasaki, T., et al., “Microbial Proline 4-Hydroxylase Screening and Gene Cloning,” Appl. Environ. Microbiol, 65 (9):4028-31 [1999].
[cited by applicant]
Simonen, M., et al., “Protein Secretion in
[cited by applicant]
Smith, M., “In vitro mutagenesis,” Ann. Rev. Genet., 19:423-462 (1985).
[cited by applicant]
Smith, T., et al., “Comparison of Biosequences,” Adv. Appl. Math, 2:482-489 (1981).
[cited by applicant]
Stellwagen, E., “Dye Affinity Chromatography,” Current Protocols in Protein Science, Chapter 9, Unit 9.2-9.2.16 [2001].
[cited by applicant]
Stemmer, W., “DNA Shuffling by Random Fragmentation and Reassembly: In vitro Recombination for Molecular Evolution,” Proc. Natl. Acad. Sci. USA, 91:10747-10751 (1994).
[cited by applicant]
Stemmer, W.P.C., “Rapid evolution of a protein in vitro by DNA shuffling”, Nature, 370:389-391 (1994).
[cited by applicant]
Stenico, M., et al., “Codon usage in Caenorhabditis elegans: delineation of translational selection and mutational biases,” Nucl. Acids Res. 22(13):2437-46 [1994].
[cited by applicant]
Suggs, S.V., et al., “Use of synthetic oligodeoxyribonucleotides for the isolation of specific cloned DNA sequenes,” In Developmental Biology Using Purified Genes (Brown et al., eds.), pp. 683-693, Academic Press (1981).
[cited by applicant]
Tiwari, S., et al., “Prediction of probable genes by Fourier analysis of genomic sequences,” Comput. Appl. Biosci. 13 (3):263-270 [1997].
[cited by applicant]
Truppo, M.D., et al., “Development of an Improved Immobilized CAL-B for the Enzymatic Resolution of a Key Intermediate to Odanacatib,” Organic Process Research & Development, 15:1033-1035 (2011).
[cited by applicant]
Uberbacher, E.C., et al., “Discovering and Understanding Genes in Human DNA Sequence Using GRAIL,” Methods Enzymol., 266:259-281 [1996].
[cited by applicant]
Vergnon, A.L., et al., “Solid-phase synthesis of a library of hydroxyproline derivatives,” J Comb Chem., 6(1):91-8 [2004].
[cited by applicant]
Villa-Komaroff, L., et al., “A bacterial clone synthesizing proinsulin,” Proc. Natl Acad. Sci. USA, 75:3727-3731 (1978).
[cited by applicant]
Wada, K., et al., “Codon usage tabulated from the GenBank genetic sequence data,” Nucl. Acids Res., 20:2111-2118 [1992].
[cited by applicant]
Wells, J.A., et al., “Cassette mutagenesis: an efficient method for generation of multiple mutations at defined sites,” Gene, 34:315-323 (1985).
[cited by applicant]
Wetmur, J. G., “DNA Probes: Applications of the Principles of Nucleic Acid Hybridization,” Crit Rev Biochem Mol Biol, 26(3/4):227-259 (1991).
[cited by applicant]
Wright, F., “The ‘effective number of codons’ used in a gene,” Gene 87:23-29 [1990].
[cited by applicant]
Yaegaki, K.,et al., “Improved high-performance liquid chromatography method for quantitation of proline and hydroxyproline in biological materials,” J Chromatogr., 356(1):163-70 [1986].
[cited by applicant]
Yi, S., et al., “Covalent immobilization of omega-transaminase from Vibrio fluvialis JS17 on chitosan beads,” Process Biochemistry 42(5): 895-898 (2007).
[cited by applicant]
Zhang, J-H., et al., “Directed evolution of a fucosidase from a galactosidase by DNA shuffling and screening,” Proc. Nat. Acad. Sci., U.S.A., 94:4504-4509 (1997).
[cited by applicant]
Zhao, H., et al., “Molecular evolution by staggered extension process (StEP) in vitro recombination,” Nat. Biotechnol., 16:258-261 (1998).
[cited by applicant]
UniProtKB Accession No. A0AOS6XAW4 dated Feb. 17, 2016.
[cited by applicant]
Altamura, M., et al., “2-Substituted penems with amino acid-related side chains: synthesis and antibacterial activity of a new series of beta-lactam antibiotics,” J Med Chem., 38(21):4244-56 [1995].
[cited by applicant]
Altschul, S., et al., “Basic local alignment search tool,” J. Mol. Biol., 215: 403-410 (1990).
[cited by applicant]
Altschul, S.F., et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs,” Nucleic Acids Res., 25(17):3389-3402 (1997).
[cited by applicant]
Baldino, Jr., F., et al., “High-Resolution in Situ Hybridization Histochemistry,” Methods Enzymology, 168:761-777 (1989).
[cited by applicant]
Batzer, M.A., “Erratum: Structure and variability of recently inserted Alu family members”, Nucleic Acids Res 19:698-699 [1991].
[cited by applicant]
Beaucage, S.L., et al., “Deoxynucleoside phosphoamidites—A new class of key intermediates for deoxypolynucleotide synthesis,” Tetrahedron Letters, 22(20):1859-62 (1981).
[cited by applicant]
Black, M.E., et al., “Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy,” Proc Natl Acad Sci USA, 93:3525-3529 (1996).
[cited by applicant]
Bolton, E.T., et al., “A General Method for the lisolation of RNA Complementary to DNA,” Proc. Natl. Acad. Sci. USA 48:1390 ( 1962).
[cited by applicant]
Botstein, D., et al., “Strategies and applications of in vitro mutagenesis,” Science, 229(4719):1193-1201, 1985.
[cited by applicant]
Breslauer, K.J., et al., “Predicting DNA duplex stability from the base sequence,” Proc. Natl. Acad. Sci. USA, 83:3746-3750 (1986).
[cited by applicant]
Cacho, R.A., et al., “Identification and Characterization of the Echinocandin B Biosynthetic Gene Cluster from Emericella rugulosa NRRL 11440,” J. Am. Chem. Soc., 134:16781-16790 [2012].
[cited by applicant]
Caldwell, R.C., et al., “Mutagenic PCR,” PCR Methods Appl., 3:S136-S140 (1994).
[cited by applicant]
Carter, P., “Site-directed mutagenesis,” Biochem. J., 237:1-7 (1986).
[cited by applicant]
Chen, K.X., et al., “Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles,” J Med Chem., 49(3):995-1005 [2006].
[cited by applicant]
Chen, K.X., et al., “Syntheses of novel 4-tert-alkyl ether proline-based 16- and 17-membered macrocyclic compounds,” J Org Chem., 67(8):2730-3 [2002].
[cited by applicant]
Christians, F.C., et al., “Directed evolution of thymidine kinase for AZT phosphorylation using DNA family shuffling,” Nat. Biotechnol., 17:259-264 (1999).
[cited by applicant]
Crameri, A., et al., “DNA shuffling of a family of genes from diverse species accelerates directed evolution”, Nature, 391:288-291 (1998).
[cited by applicant]
Crameri, A., et al., “Improved green fluorescent protein by molecular evolution using DNA shuffling,”Nat. Biotechnol., 14(3):315-319 (1996).
[cited by applicant]
Crameri, A., et al., “Molecular evolution of an arsenate detoxification pathway by DNA shuffling,” Nat. Biotechnol., 15 (5):436-438 (1997).
[cited by applicant]
Dale, S.J., et al., “Oligonucleotide-directed random mutagenesis using the phosphorothioate method,” Methods Mol. Biol., 57:369-74 (1996).
[cited by applicant]
De Boer, H.A., et al., “The tac promoter: A functional hybrid derived from the trp and lac promoters,” Proc. Natl Acad. Sci. USA, 80: 21-25 (1983).
[cited by applicant]
Efimov, V.A., et al., “Hydroxyproline-based DNA mimics provide an efficient gene silencing in vitro and in vivo,” Nucleic Acids Res., 34(8):2247-2257 [2006].
[cited by applicant]
Eguchi, C., et al., “The novel synthesis of L-Hydroxyproline from D-Glutamic Acid,” Bull. Chem. Soc. Japan, 47 (7):1704-08 [1974].
[cited by applicant]
Fasman, G.D.,CRC Practical Handbook of Biochemistry and Molecular Biology, CRC Press, Boca Raton, FL, pp. 3-70 [1989].
[cited by applicant]
Freier, S.M., et al., “Improved free-energy parameters for predictions of RNA duplex stability,” Proc. Natl. Acad. Sci USA, 83:9373-9377 (1986).
[cited by applicant]
Guo, Z., et al., “3′-End-Forming Signals of Yeast mRNA,” Mol. Cell. Biol., 15(11):5983-5990 [1995].
[cited by applicant]
Hara, R., “Characterization of novel 2-oxoglutarate dependent dioxygenases converting L-proline to cis-4-hydroxy-I-proline,” Biochem Biophys Res Commun., 379(4):882-6 [2009].
[cited by applicant]
Henaut and Danchin in Neidhardt et al. [eds.],
[cited by applicant]
Henikoff, S., et al., “Amino acid substitution matrices from protein blocks,” Proc. Natl. Acad. Sci., 89:10915-10919 (1992).
[cited by applicant]
Houwaart, S., et al., “Pneumocandin Biosynthesis: Involvement of a trans-Selective Proline Hydroxylase,” ChemBioChem, 15:2365-2369 [2014].
[cited by applicant]
Kierzek, R., et al., “Polymer-Supported RNA Synthesis and Its Application To Test the Nearest-Neighbor Model for Duplex Stability,” Biochemistry, 25:7840-7846 (1986).
[cited by applicant]
Klein, C., et al., “A Simple Procedure for Selective Hydroxylation of I-Proline and I-Pipecolic Acid with Recombinantly Expressed ProlineHydroxylases,” Adv Synth. Catal., 353:1375-1383 [2011].
[cited by applicant]
Koszelewski, D., et al., “Immobilization of omega-transaminases by encapsulation in a sol-gel/celite matrix,” Journal of Molecular Catalysis B: Enzymatic, 63: 39-44 (2010).
[cited by applicant]
Kramer, B., et al., “Different base/base mismatches are corrected with different efficiencies by the methyl-directed DNA mismatch-repair system of
[cited by applicant]
Lawrence, C.C., et al., “Purification and initial characterization of proline 4-hydroxylase from Streptomyces griseoviridus P8648: a 2-oxoacid, ferrous-dependent dioxygenase involved in etamycin biosynthesis,” Biochem. …
[cited by applicant]
Lee, Y.K., et al., “The novel synthesis of two diastereomers of gamma-hydroxyproline,” Bull. Chem. Soc. Japan, 46:2924-26 [1973].
[cited by applicant]
Ling, M., et al., “Approaches to DNA Mutagenesis:An Overview,” Anal. Biochem., 254:157-78 (1997).
[cited by applicant]
Majamaa, K., et al., “Differences between collagen hydroxylases and 2-oxoglutarate dehydrogenase in their inhibition by structural analogues of 2-oxoglutarate,” Biochem. J., 229:127-133 [1985].
[cited by applicant]
Martin, A.R., et al., “Characterization of free and immobilized (S)-aminotransferase for acetophenone production,” Applied Microbiology and Biotechnology, 76(4): 843-851 (2007).
[cited by applicant]
Mateo, C., et al., “Epoxy sepabeads: a novel epoxy support for stabilization of industrial enzymes via very intense multipoint covalent attachment,” Biotechnology Progress 18(3):629-34 (2002).
[cited by applicant]
Matsui, M., et al., “Identification of a putative FR901469 biosynthesis gene cluster in fungal sp. No. 11243 and enhancement of the productivity by overexpressing the transcriptionfactor gene frbF,” J. Biosci. Bioeng., …
[cited by applicant]
Matthes, H.W.D., et al., “Simultaneous rapid chemical synthesis of over one hundred oligonucleotides on a microscale,” EMBO J., 3(4):801-05 (1984).
[cited by applicant]
McInerney, J.O., “GCUA: general codon usage analysis,” Bioinformatics, 14(4):372-73, 1998.
[cited by applicant]
Minshull, J., et al., “Protein evolution by molecular breeding,” Curr. Op. Chem. Biol., 3(3):284-290 (1999).
[cited by applicant]
Mori, H., et al., “Detection of Novel Proline 3-Hydroxylase Activities in
[cited by applicant]
Nakamura, Y., et al., “Codon usage tabulated from international DNA sequence databases: status for the year 2000,” Nucl. Acids Res., 28:292 [2000].
[cited by applicant]
Needleman, S., et al., “A general method applicable to the search for similarities in the amino acid sequence of two proteins,” J. Mol. Biol. 48:443-453 (1970).
[cited by applicant]
O'Connell, C.E., et al., “Synthesis and evaluation of some hydroxyproline-derived peptidomimetics as isoprenyltransferase inhibitors” Chem Pharm Bull., 48(5):740-742 [2000].
[cited by applicant]
Pearson, W.R., “Improved tools for biological sequence comparison,” Proc. Nat'l. Acad. Sci. USA, 85:2444-2448 (1988).
[cited by applicant]
Petersen, L. et al., “Novel proline hydroxylase activities in the pneumocandin-producing fungus
[cited by applicant]